Course Credit: 1 hour

This Capsule on the Pharmacology of Intracranial Pressure Management delves into the differences between agents to treat cerebral edema, goal setting for blood pressure in the setting of intracranial hemorrhage, as well as the various antihypertensive agents used to achieve those goals.
Learning Objectives
- Evaluate different hyperosmolar agents for reducing intracranial pressure
- Select goal systolic blood pressure targets based on type of neurologic injury
- Design an antihypertensive regimen incorporating patient specific factors to achieve recommended blood pressure goals
Intracranial Pressure – Course Contributors
Author | Affiliation | |
---|---|---|
Jamie M. Rosini, PharmD, MS, BCPS, BCCCP, DABAT | Emergency Medicine Pharmacist, Christiana Care Health System | @jrozzini |
Ashley N. Martinelli, PharmD, BCCCP | Emergency Medicine Pharmacist, University of Maryland Medical Center | @RxMartinelli |
Reviewer | Affiliation | |
---|---|---|
PharmD Reviewer: Glenn Oettinger, PharmD | Thomas Jefferson University Hospital | @glennoettinger |
Editor | Affiliation | |
---|---|---|
Copy Editor: Emily Wiener, PharmD | Emergency Medicine Pharmacist, Baltimore Washington Medical Center | @PharmdEMily |
Associate Editor: Nadia Awad, PharmD, BCPS | Emergency Medicine Pharmacist, Robert Wood Johnson University Hospital | @Nadia_EMPharmD |
Lead Editor: Bryan Hayes, PharmD, FAACT, FASHP | Clinical Pharmacy Manager, Massachusetts General Hospital | @PharmERToxGuy |
How fast would you administer HTS 3% or 23.4%? How fast would you administer mannitol depending if you are using the 25% vials or the 20% bags?
Hi Mary: I got this response from Bryan Hayes:
“HTS 3% can be administered as a bolus. HTS 23.4% is usually administered over 1-20minutes. We use a syringe pump for it. Mannitol is administered over 20-30 minutes. Anything faster causes hypotension.”
Bryan D. Hayes, PharmD, DABAT, FAACT, FASHP
Clinical Pharmacy Manager – Emergency Medicine, Pediatrics, & Overnight Services
Assistant Professor – Department of EM, Division of Toxicology
Immediate Past-President, American Board of Applied Toxicology (ABAT)
Massachusetts General Hospital | Harvard Medical School